CATX Perspective Therapeutics Inc.
Health Care, filed as PERSPECTIVE THERAPEUTICS INC (COM NEW), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab
In 2026 Q2 James Silverman sold out of Perspective Therapeutics.
Who owns this now
Largest portfolio weights among holders, up to 3.4% (David Witzke, Avidity Partners Management). Not free-float ownership.
Who owns CATX
Sorted by value, long equity only, as of 2026 Q2. Exits show their last held size.
| History | |||||
|---|---|---|---|---|---|
| David Witzke, Avidity Partners Management | Small add +4.1% | 6,299,999 | $21M | History | |
| James Silverman, Opaleye Management exited 2026 Q2 Last 2026 Q1 | Exit −2.57% | 4,675,000 | $19M | History |
Insider trades
Open-market buys and sales by CATX's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $42K bought by 2 insiders
- $1.6M sold by 2 insiders outside a trading plan
- None no planned (10b5-1) sales
-
Lantheus Alpha Therapy, LLC 10% owner, +1 joint filerSale$777K 247,932 shares at $3.13 2.2% of stakeTraded Sep 3–4 Filed Sep 8
-
Lantheus Alpha Therapy, LLC 10% owner, +1 joint filerSale$131K 42,129 shares at $3.11 0.4% of stakeTraded Sep 2 Filed Sep 4
-
Lantheus Alpha Therapy, LLC 10% ownerSale$357K 113,914 shares at $3.14 1% of stakeTraded Aug 31–Sep 1 Filed Sep 4
-
Lantheus Holdings, Inc. 10% ownerSale$112K 35,769 shares at $3.12 0.3% of stakeTraded Sep 1 Filed Sep 3
-
Lantheus Holdings, Inc. 10% ownerSale$246K 78,145 shares at $3.14 0.7% of stakeTraded Aug 31 Filed Sep 2
-
Jonathan Robert Hunt Chief Accounting OfficerBuy$22K 11,000 shares at $2.03 +23% to stakeTraded Nov 13, 2025 Filed Nov 17, 2025
-
Robert F Williamson III DirectorBuy$20K 9,498 shares at $2.10 +2595% to stakeTraded Nov 12, 2025 Filed Nov 14, 2025
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,8.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,8.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,8.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc |
No filings match this filter.
Financials
US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.
Income statement
Balance sheet
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total current assets | $16.84M | $231.16M | $148.39M |
| Total non-current assets * | $81.05M | $109.94M | $118.58M |
| Total assets | $97.89M | $341.1M | $266.97M |
| Total current liabilities | $15.66M | $18.23M | $28.68M |
| Total non-current liabilities * | $7.05M | $32.2M | $31.26M |
| Total equity | $75.18M | $290.67M | $207.03M |
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.